BlackRock Group’s Imunon IMNN Stock Holding History

BlackRock Group’s Portfolio IMNN Stock Details IMNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-3	Closed	-$37K	–	2726
2013 Q3	$37K	Buy	+3	New	+$44.3K	﹤0.01%	2748

Other funds holding IMNN

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Group's IMNN Position: Q4 2013 in Review

BlackRock Group sold out of Imunon (IMNN) in Q4 2013, closing a stake of 3 shares — an estimated $37K sold.

BlackRock Group first reported a position in IMNN in Q3 2013 and held it in 1 quarter. The position peaked at $37K in Q3 2013. 25 funds tracked by Wall St. Rank hold IMNN as of Q4 2013.

BlackRock Group reported no remaining Imunon position as of Q4 2013 after selling out during the quarter.
BlackRock Group sold 3 Imunon shares in Q4 2013, an estimated $37K.
BlackRock Group first reported a position in Imunon in Q3 2013 and held it in 1 quarter.
BlackRock Group's Imunon position peaked at $37K in Q3 2013.
25 funds tracked by Wall St. Rank held Imunon as of Q4 2013.

Based on BlackRock Group's 13F filing for Q4 2013, filed 12 Feb 2014.